Senior insider sale
SVP, Diagnostics, clonoSEQ at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$445.7K
16.94K shares
What this filing means
BOBULSKY SUSAN plans to sell 16.94K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $445.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/6/2026ACC: 0001950047-26-010075
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
16.94K
Shares to sell
$445.7K
Approx. market value
6.44K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/4/2023
6.44KTotal acquired6.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2023 | Restricted Stock Units N/A | 6.44K | — |
| Total | 6.44K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.20K
Market value
$32.3K
9/15/2026
—Completed
Units to sell
3K
Market value
$75.0K
8/10/2026
—Completed
Units to sell
1.30K
Market value
$31.2K
7/30/2026
—Completed
Units to sell
5K
Market value
$115.0K
7/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.44K
Market value
$192.3K
10/6/2026
Total
Units
16.94K
Value
$445.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/15/2026 | 1.20K | $32.3K | — | Completed |
8/10/2026 | 3K | $75.0K | — | Completed |
7/30/2026 | 1.30K | $31.2K | — | Completed |
7/16/2026 | 5K | $115.0K | — | Completed |
| Planned — Approximate Date | ||||
10/6/2026 | 6.44K | $192.3K | NASDAQ | Planned |
| Total | 16.94K | $445.7K | ||